Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 477 Jan 1 – Oct 25, 2026
- Disclosed funding
- $20.2B 403 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
 AcurionCompany profile AI analysis of routine pathology images to identify cancer biomarkers for precision oncology. AI analysis of routine pathology images to identify cancer biomarkers for precision oncology. | $4.3M | Seed | Biotech, Healthtech | United States | Investors | |
| G Generates molecular data for drug development | €20M | Series A | Biotech | France | Investors | |
| F Develops biotech-powered hair supplements using proprietary microencapsulation | Undisclosed | Follow-OnUndisclosed | Biotech | United Kingdom | Investors | |
 Ambrosia BiosciencesCompany profile Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders. Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders. | $100M | Series B | Biotech | United States | Investors | |
| SB Scala BiodesignCompany profile Develops computational protein design technologies for therapeutic and industrial applications Develops computational protein design technologies for therapeutic and industrial applications | $16M | Series A | Biotech | Israel | Investors | |
| TB TippingPoint BiosciencesCompany profile Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer | $4.5M | Seed | Biotech | United States | Investors | |
| SO Standing OvationCompany profile Produces high-quality casein from whey permeates using precision fermentation Produces high-quality casein from whey permeates using precision fermentation | €30M | Series B | Biotech, Foodtech | France | Investors | |
| S Develops next-generation cell assay technology for drug discovery | $3.8M | Undisclosed | Biotech | United Kingdom | Investors | |
| O ONCOMATRYXCompany profile Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors | $67M | Series B | Biotech | Spain | Investors | |
| C CentivaxCompany profile Develops vaccines and therapies for universal protection against diverse targets Develops vaccines and therapies for universal protection against diverse targets | $37M | Undisclosed | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
23rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.